MRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant

Bezawit A. Woldemeskel; Caroline C. Garliss; Joel N. Blankson

doi:10.1093/cid/ciab915

MRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant

Bezawit A. Woldemeskel, Caroline C. Garliss, Joel N. Blankson

Research output: Contribution to journal › Article › peer-review

Abstract

Little is known about the decay kinetics of coronavirus disease 2019 vaccine-elicited severe acute respiratory syndrome coronavirus 2-specific T cells. In this study we show a modest decline in the frequency of these T cells at 6 months and demonstrate robust expansion in response to antigen and recognition of spike peptides from the Delta variant.

Original language	English (US)
Pages (from-to)	E898-E901
Journal	Clinical Infectious Diseases
Volume	75
Issue number	1
DOIs	https://doi.org/10.1093/cid/ciab915
State	Published - Jul 1 2022
Externally published	Yes

Keywords

COVID
Delta variant
SARS-CoV-2
T cells
mRNA vaccines

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciab915

Cite this

@article{a1a7bd69bf8a4091b6ad83eb7a2a3a92,

title = "MRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant",

abstract = "Little is known about the decay kinetics of coronavirus disease 2019 vaccine-elicited severe acute respiratory syndrome coronavirus 2-specific T cells. In this study we show a modest decline in the frequency of these T cells at 6 months and demonstrate robust expansion in response to antigen and recognition of spike peptides from the Delta variant.",

keywords = "COVID, Delta variant, SARS-CoV-2, T cells, mRNA vaccines",

author = "Woldemeskel, {Bezawit A.} and Garliss, {Caroline C.} and Blankson, {Joel N.}",

year = "2022",

month = jul,

day = "1",

doi = "10.1093/cid/ciab915",

language = "English (US)",

volume = "75",

pages = "E898--E901",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - MRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant

AU - Woldemeskel, Bezawit A.

AU - Garliss, Caroline C.

AU - Blankson, Joel N.

PY - 2022/7/1

Y1 - 2022/7/1

N2 - Little is known about the decay kinetics of coronavirus disease 2019 vaccine-elicited severe acute respiratory syndrome coronavirus 2-specific T cells. In this study we show a modest decline in the frequency of these T cells at 6 months and demonstrate robust expansion in response to antigen and recognition of spike peptides from the Delta variant.

AB - Little is known about the decay kinetics of coronavirus disease 2019 vaccine-elicited severe acute respiratory syndrome coronavirus 2-specific T cells. In this study we show a modest decline in the frequency of these T cells at 6 months and demonstrate robust expansion in response to antigen and recognition of spike peptides from the Delta variant.

KW - COVID

KW - Delta variant

KW - SARS-CoV-2

KW - T cells

KW - mRNA vaccines

UR - http://www.scopus.com/inward/record.url?scp=85137124927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137124927&partnerID=8YFLogxK

U2 - 10.1093/cid/ciab915

DO - 10.1093/cid/ciab915

M3 - Article

C2 - 34694362

AN - SCOPUS:85137124927

SN - 1058-4838

VL - 75

SP - E898-E901

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 1

ER -

MRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this